远望谷(002161) - 2025 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2025 was ¥91,386,860.38, a decrease of 16.24% compared to ¥109,111,915.36 in the same period last year[4] - The net profit attributable to shareholders was a loss of ¥24,226,292.76, representing a decline of 127.98% from a profit of ¥86,585,831.40 in the previous year[4] - The basic earnings per share for Q1 2025 was -¥0.0327, down 127.95% from ¥0.117 in Q1 2024[4] - Net profit for the period was a loss of ¥25,807,513.78, compared to a profit of ¥85,203,110.53 in the previous period, indicating a significant decline[22] - The company's operating profit turned negative at ¥-26,710,650.33, down from ¥99,776,101.01 in the prior year[22] - Basic and diluted earnings per share were both ¥-0.0327, compared to ¥0.117 in the previous period[22] Cash Flow and Liquidity - The net cash flow from operating activities improved to -¥8,584,957.16, a 61.82% increase compared to -¥22,484,598.72 in the previous year[11] - Operating cash flow for the current period was -8,584,957.16 CNY, an improvement from -22,484,598.72 CNY in the previous period[24] - Total cash inflow from operating activities was 152,342,160.19 CNY, compared to 116,883,455.49 CNY in the prior period, representing an increase of approximately 30.3%[24] - Cash outflow from operating activities totaled 160,927,117.35 CNY, up from 139,368,054.21 CNY, indicating a rise of about 15.5%[24] - Investment activities resulted in a net cash flow of -42,996,391.33 CNY, worsening from -22,924,244.16 CNY in the previous period[24] - Cash inflow from financing activities was 133,890,000.00 CNY, compared to 118,549,967.26 CNY, marking an increase of approximately 12.9%[24] - Net cash flow from financing activities was 16,960,710.20 CNY, down from 20,902,674.53 CNY in the prior period[24] - The ending cash and cash equivalents balance was 119,591,657.04 CNY, an increase from 74,521,291.78 CNY in the previous period[25] - The company received 2,000,000.00 CNY from minority shareholders as part of investment activities[24] - Cash received from the sale of fixed assets was 300.00 CNY, a decrease from 3,517.50 CNY in the previous period[24] - The company reported a foreign exchange impact of 634,367.46 CNY on cash and cash equivalents[24] Assets and Liabilities - The company's total assets at the end of Q1 2025 were ¥2,705,442,390.01, a slight increase of 0.22% from ¥2,699,505,021.46 at the end of the previous year[4] - Total assets increased slightly to ¥2,705,442,390.01 from ¥2,699,505,021.46[19] - Total liabilities rose to ¥1,190,342,758.00 from ¥1,163,813,202.39, reflecting an increase of approximately 2.2%[19] - The company's equity attributable to shareholders decreased to ¥1,509,779,712.09 from ¥1,530,804,455.11, a decline of about 1.4%[19] - The company's total current assets amount to 1,182,763,486.85 CNY, an increase from 1,174,837,740.15 CNY at the beginning of the period[17] - The company's cash and cash equivalents decreased by 44.52% to -¥33,986,270.83, primarily due to increased cash outflows from investment activities[11] - The company's long-term equity investments decreased slightly by 0.53% to ¥272,655,700.89[7] Shareholder Information - The total number of common shareholders at the end of the reporting period is 68,006[14] - Major shareholder Xu Yusuo holds 15.31% of the company's shares, totaling 113,262,513 shares, with 108,660,000 shares pledged[15] - The total number of shares under pledge represents 14.69% of the total shares outstanding[15] - The company has no outstanding preferred shareholders or related changes in the top 10 shareholders[15] Operating Costs and Expenses - The company's operating costs decreased by 14.28% to ¥54,673,924.43, aligning with the revenue decline[10] - Total operating costs decreased to ¥109,523,329.08 from ¥122,326,361.65, a reduction of about 10.5% year-over-year[21] - Research and development expenses were ¥11,819,810.88, down from ¥12,745,665.65, a decrease of approximately 7.3% year-over-year[21] Investment Performance - The company reported a significant drop in fair value gains, with a loss of ¥8,676,938.08 compared to a gain of ¥110,748,660.87 in the same period last year, a decline of 107.83%[10] - The company reported an investment loss of ¥-1,440,969.49, compared to a gain of ¥829,109.01 in the previous period[22]